“It’s about good communication.” How often have we heard this wisdom when it comes to personal or professional situations? We have all experienced how a failure to communicate can derail a situation or relationship because our messages were misunderstood or misspoken. Continue reading
According to the Alberta Bone and Joint Health Institute, arthritis has devastating and debilitating effects on the lives of more than 500,000 Albertans. It is also the leading cause of work disability in Alberta, with nearly three out of every five people with arthritis of working age, costing Alberta’s economy $3.3 billion in direct and indirect costs.
Arthritis Consumer Experts sent an open letter and survey to all candidates in the upcoming May 5th Alberta provincial election, asking them how their Party plans to improve arthritis prevention, treatment and care.
Candidate responses can be viewed on our website. Click on Alberta Election 2015 where you will find responses categorized by party and arranged according to the date we receive them.
A checkup appointment at my rheumatologist (doctor who specializes in arthritis) always leads to some interesting discussions. Most of the time I try to “research” a topic beforehand, so that I am armed with the latest background information on whatever are my most pressing concerns at the time. When I launch into my questions (I always have a list written out), I have a better-than-even chance of holding a meaningful conversation with my rheumy. In turn, I get more out of the conversation instead of returning home with questions that even Google cannot answer. Understanding what he is really saying provides me with the sense that I am in control of my ankylosing spondylitis (AS), and not the other way around (AS controlling me?) Continue reading
Canadian Rheumatology Association (CRA) and Allied Health Professions Association (AHPA) Interview Series 2015
Today’s feature interview – Dr. Glen Hazlewood: Treatment preference of patients with early rheumatoid arthritis
ABN reporters from Canada’s arthritis consumer organizations interviewed leading health professionals and researchers during last month’s CRA and AHPA annual meetings.
Beginning March 9, feature interviews will be posted on the ABN YouTube channel http://bit.ly/ABNYouTube. Please help us raise awareness about the important work going on in Canada by sharing the interviews with your organizational and social networks.
About Dr. Glen Hazlewood (from Arthritis Research Canada)
Dr. Glen Hazlewood is a practicing rheumatologist in Calgary and is currently working towards his PhD in Clinical Epidemiology through the Institute of Health, Policy, Management and Evaluation, University of Toronto. His PhD co-supervisors are Dr. Deborah Marshall and Dr. Claire Bombardier. Continue reading
A clinical symposium yesterday at the ACR called New Frontiers in Osteoarthritis Treatment: The Role of Weight Loss, Surgery and Current Treatment Guidelines looked at the management of osteoarthritis (OA) patients through weight loss and exercise, surgery, and medications. The session also looked at the differences in treatment recommendations for OA.
Osteoarthritis and weight loss and exercise
In an interview with ACR Daily News, Stephen P. Messier, PhD, Professor of Health and Exercise Science at Wake Forest University, said: “When combined with exercise, weight loss is a level 1 method of treatment for knee osteoarthritis, and there’s strong support for both weight loss and exercise as the first-line treatment for knee osteoarthritis. I think the problem is that patients don’t know how to do it.”
New guidelines were recently drafted in an effort to raise awareness among doctors that psoriatic arthritis affects more than just skin and joints, and that there are several comorbidities associated with the disease.
Comorbidities of psoriatic arthritis include cardiovascular disease, uveitis (eye inflammation), obesity, and inflammatory bowel disease in addition to the symptoms commonly associated with the disease: psoriasis, painful and swollen joints, morning stiffness, reduced range of motion, and general fatigue. Continue reading